.webp)
Key takeaways:
- IBS experts including Dr. Simone Peters, Dr. Prashant Singh, and Dr. Megan Riehl explore the future of digital therapeutics for IBS.
- The panel discusses Monash University randomized control trial breakthroughs on gut-directed hypnotherapy and the efficacy of app-delivered programs for improving symptom severity.
- Panelists share practical steps clinicians can take to integrate digital hypnotherapy into care plans and improve patient quality of life.
- The research discussed supports a non-pharmacological approach to alleviating the psychological symptoms that often accompany IBS.
IBS experts Ellie Anderson, Dr. Simone Peters, Beth Rosen, Dr. Prashant Singh, and Dr. Megan Riehl explore the future of digital therapeutics for IBS. Discover Monash University randomized control trial (RCT) breakthroughs on gut-directed hypnotherapy (GDH) and how it can best support you, your clinic, and your IBS patients.
The panelists discussed:
The clinical impact of digital therapeutics on IBS pain management.
The efficacy of app-delivered GDH for improving symptom severity.
Practical steps for clinicians to integrate digital hypnotherapy into care plans to improve patient quality of life.
How the research supports a non-pharmacological approach to alleviating IBS-related psychological symptoms.
Complete the form to watch the full panel video.
Refer your patients to Nerva using our HIPAA-compliant form
